Drugs / Nissle 1917
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02276508 | Oct → Dec 2014 | urinary tract infection | Elizabeth Lucas | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01469273 | Nov 2011 → May 2013 | infantile diarrhea | Hospital San Bartolome | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nissle 1917 | “ECN-SUSPENSION is a probiotic containing viable E. coli bacteria of the non-pathogenic Nissle 1917 strain at a concentration of 10exp8 cells per ml.” NCT01469273 ↗ |
| Modality | Other / unclassified | “Nissle 1917 is an E. coli based probiotic” NCT02276508 ↗ |
| Route | Oral | “orally administered medication” NCT02276508 ↗ |